SEC Form 4 · accession 0001237899-15-000067
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Aberman
Officer — SVP Strategy Investor Relation
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2015 | M | 4,000 | $24.00 | A | 16,498 | D | |
| Common Stock | holding | — | — | — | 407 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $24.00 | Dec 17, 2015 | M | 4,000 | D | — | Mar 22, 2020 | Common Stock | 4,000 | 166 | D |
| Non-Qualified Stock Option (right to buy)F2 | $555.67 | Dec 16, 2015 | A | 25,500 | A | — | Dec 16, 2025 | Common Stock | 25,500 | 25,500 | D |
Explanation of responses
- F1The stock option award (combined incentive stock option and non-qualified stock option) vests over five years, commencing one year after the date of grant. 12,500 options vest on the first anniversary, 25,000 options vest on the second anniversary, 25,000 options vest on the third anniversary, 25,000 options vest on the fourth anniversary, and 12,500 options vest on the fifth anniversary of the date of grant.
- F2The stock option award vests in four equal annual installments, commencing one year after the date of grant.